Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010;24(4):273-7.
doi: 10.1002/jcla.20399.

Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?

Aysel Kiyici  1 , Idris Mehmetoğlu, Hatice Karaoğlan, Hüseyin Atalay, Yalçin Solak, Süleyman Türk
Affiliations
Comparative Study

Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?

Aysel Kiyici et al. J Clin Lab Anal. 2010.

Abstract

Ischemia-Modified albumin (IMA) has been used as an early marker in the evaluation of the patients with acute coronary syndrome. We aimed to evaluate IMA in end-stage renal disease (ESRD) patients on hemodialysis and the effect of albumin methods on albumin-adjusted IMA levels. A total of 30 ESRD patients were included in this study. Serum IMA and albumin levels were measured before and after a hemodialysis session. Albumin concentrations were determined with bromocresol green and bromocresol purple methods. Postdialysis IMA and albumin-adjusted IMA levels with two different albumin methods were significantly increased compared with the predialysis levels (P<0.05). However, we did not find any difference in albumin-adjusted IMA levels in either at the beginning or at the end of the dialysis session. IMA levels increase after hemodialysis, whereas albumin method has no effect on albumin-adjusted IMA levels.

PubMed Disclaimer

References

    1. Bar‐Or D, Lau E, Winkler JV. A novel assay for cobalt‐albumin binding and its potential as a marker for myocardial ischemia—A preliminary report. J Emer Med 2000;19:311–315. - PubMed
    1. Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischaemia and myocardial infarction. Clin Chem 2003;49:581–585. - PubMed
    1. Bar‐Or D, Lau E, Rao N, Bampos N, Winkler JV, Curtis CG. Reduction in the cobalt‐binding capacity of human albumin with myocardial ischaemia. Ann Emer Med 1999;34:S56.
    1. Peacock F, Morris DL, Anwaruddin S, et al. Meta‐analysis of ischemia‐modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006;152:253–262. - PubMed
    1. Troxler M, Thompson D, Homer‐Vanniasinkam S. Ischaemic skeletal muscle increases serum ischaemia modified albumin. Eur J Vasc Endovasc Surg 2006;31:164–169. - PubMed

Publication types